208 related articles for article (PubMed ID: 36214671)
21. SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.
Ensign SP; Roos A; Mathews IT; Dhruv HD; Tuncali S; Sarkaria JN; Symons MH; Loftus JC; Berens ME; Tran NL
Mol Cancer Res; 2016 Mar; 14(3):302-12. PubMed ID: 26764186
[TBL] [Abstract][Full Text] [Related]
22. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
[TBL] [Abstract][Full Text] [Related]
23. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
[TBL] [Abstract][Full Text] [Related]
24. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
Gurunathan S; Winkles JA; Ghosh S; Hayden MS
J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
[TBL] [Abstract][Full Text] [Related]
25. The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.
Tajrishi MM; Zheng TS; Burkly LC; Kumar A
Cytokine Growth Factor Rev; 2014 Apr; 25(2):215-25. PubMed ID: 24444596
[TBL] [Abstract][Full Text] [Related]
26. TWEAK/Fn14 signaling in tumors.
Hu G; Zeng W; Xia Y
Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
[TBL] [Abstract][Full Text] [Related]
27. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
[TBL] [Abstract][Full Text] [Related]
28. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
29. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
Burkly LC; Michaelson JS; Zheng TS
Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
[TBL] [Abstract][Full Text] [Related]
30. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.
Son A; Oshio T; Kawamura YI; Hagiwara T; Yamazaki M; Inagaki-Ohara K; Okada T; Wu P; Iseki M; Takaki S; Burkly LC; Dohi T
Mucosal Immunol; 2013 Nov; 6(6):1131-42. PubMed ID: 23462911
[TBL] [Abstract][Full Text] [Related]
31. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
[TBL] [Abstract][Full Text] [Related]
32. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
[TBL] [Abstract][Full Text] [Related]
33. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
[TBL] [Abstract][Full Text] [Related]
34. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.
Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J
J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850
[TBL] [Abstract][Full Text] [Related]
35. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
[TBL] [Abstract][Full Text] [Related]
36. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS
EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496
[TBL] [Abstract][Full Text] [Related]
37. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
38. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
39. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
40. TWEAK and TRAF6 regulate skeletal muscle atrophy.
Kumar A; Bhatnagar S; Paul PK
Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):233-9. PubMed ID: 22366923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
